caprylates has been researched along with Movement Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, M; Imagama, S; Ishiguro, N; Matsuyama, Y; Miyagi, M; Shinjo, R; Sugiura, Y; Tsutsumi, K; Yasuda, T | 1 |
| Araki, T; Kato, H; Kurosaki, R; Oki, C | 1 |
2 other study(ies) available for caprylates and Movement Disorders
| Article | Year |
|---|---|
Arundic acid (ONO-2506) inhibits secondary injury and improves motor function in rats with spinal cord injury.
Topics: Animals; Caprylates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Kaplan-Meier Estimate; Movement Disorders; Muscle Strength; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors; Tubulin | 2014 |
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Microglia; Movement Disorders; MPTP Poisoning; Neurons; Neuroprotective Agents; S100 Proteins | 2004 |